Back to search
FDAFDA · Food and drugs·Recall number D-1880-2019

Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001.

Published October 2, 2019 · Recall initiated: August 29, 2019

Summary

FDA records drug Class II recall D-1880-2019, published October 2, 2019 and initiated August 29, 2019. Recalling firm: Johnson Matthey Inc.; Status: Terminated; Reported quantity: 52882.23 grams; Lot: Lot #: B0030-180101, B0030-180102, Exp. Feb 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Potential glass contamination

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Johnson Matthey Inc.
Distributor
Nationwide within the United States
Lot
Lot #: B0030-180101, B0030-180102, Exp. Feb 2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001. recalled?

Yes. FDA published recall D-1880-2019 on October 2, 2019. Reported hazard: cGMP Deviations: Potential glass contamination

What should I do if I have this product?

Voluntary: Firm initiated · Letter